Surevest’s DexCom DXCM Stock Holding History

Surevest’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$26K	Sell	320 -4	-1%	-$339	0.01%	223
2022 Q2	$24K	Buy	324 +320	+8,000%	+$29.2K	0.01%	247
2022 Q1	$1K	Hold	4	–	–	﹤0.01%	452
2021 Q4	$1K	Buy	+4	New	+$575	﹤0.01%	462

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Surevest's DXCM Position: Q3 2022 in Review

Surevest reduced its DexCom (DXCM) stake by 1.2% in Q3 2022, selling an estimated $339 and leaving 320 shares worth $26K. The position accounts for 0.01% of the portfolio, ranked #223.

Surevest first reported a position in DXCM in Q4 2021 and has held it in 4 quarters since. 794 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

Surevest held 320 shares of DexCom worth $26K as of Q3 2022.
Surevest sold 4 DexCom shares in Q3 2022, an estimated $339.
DexCom made up 0.01% of Surevest's portfolio in Q3 2022, its #223 holding.
Surevest first reported a position in DexCom in Q4 2021 and has held it in 4 quarters since.
794 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.